Canadian Organization for Rare Disorders

Recent papers from Canadian Organization for Rare Disorders

1. Rethinking rare disease diagnosis in CanadaOpen Access Government · 2026
2. Connecting Canada for rare disease care and researchOpen Access Government · 2025
3. Redefining value assessment and healthcare funding priorities for medicines: the journey to patient-centric decision making in APAC – a systematic literature reviewInternational Journal of Technology Assessment in Health Care · 2025
4. Genetics Navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populationsBMJ Open · 2024
5. Sustainable approaches for drug repurposing in rare diseases: recommendations from the IRDiRC Task ForceRare Disease and Orphan Drugs Journal · 2023
6. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsExpert Review of Pharmacoeconomics & Outcomes Research · 2021
7. Disease progression in recently diagnosed patients with inherited marrow failure syndromes: A Canadian inherited marrow failure registry (CIMFR) reportPediatric Blood & Cancer · 2006